Karakulov Rk 1

1. Immune polychemotherapy regimen choice in B-cell non-Hodgkin lymphoma of high and low malignancy based on the identification of the mutational c-myc and BCL 2 genes
2. Differentiated approach in the treatment of diffuse large B-cell lymphoma according to c-MYC and BCL2 status
1